Treatment of Premature Retinopathy with Biosimilar Ranibizumab Seems Effective.

Published Date: 27 Apr 2023

Treatment of Retinopathy of Prematurity with Biosimilar Ranibizumab Seems Effective.

Read Full News

Latest News

Common Epilepsy Drug Tied to Increased Glaucoma Risk

Use of topiramate is linked to a higher risk for glaucoma than valproate or lamotrigine, especially in women and patients with epilepsy, new research shows.

Worsening Heart-Kidney-Metabolic Health May Threaten Vision

People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular degeneration.

Beyond Skin Deep: Biologics May Benefit Eyes in Psoriasis

In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis, and keratitis — but they do not consistently alleviate retinal disease.

Study Maps Extensive Disease Links Beyond Childhood Eczema

Using millions of NHS records, researchers mapped extensive links between childhood eczema and later inflammatory and eye diseases.

Neoadjuvant Therapy Use Rising Sharply in Cancer Care

The second annual NCDB report reveals a major shift toward preoperative systemic therapy in solid tumors, offering new opportunities for de-escalation, although careful patient selection is needed.

New Rx Option for Neuromyelitis Optica Spectrum Disorder?

Phase 3 trial results suggest daratumumab, which is approved for multiple myeloma, may also be effective at reducing relapse risk in neuromyelitis optica spectrum disorder.

Todays Updates

Conditional EU Nod for Weekly Pill in Pediatric Glioma

Current treatment options include surgery and chemotherapy, but chemotherapy’s benefits are often modest and can cause substantial side effects.

Todays Updates

Conditional EU Nod for Weekly Pill in Pediatric Glioma

Current treatment options include surgery and chemotherapy, but chemotherapy’s benefits are often modest and can cause substantial side effects.

Latest News

Use of topiramate is linked to a higher risk for glaucoma than valproate or lamotrigine, especially in women and patients with epilepsy, new research shows.

People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular degeneration.

In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis, and keratitis — but they do not consistently alleviate retinal disease.

Using millions of NHS records, researchers mapped extensive links between childhood eczema and later inflammatory and eye diseases.

The second annual NCDB report reveals a major shift toward preoperative systemic therapy in solid tumors, offering new opportunities for de-escalation, although careful patient selection is needed.

Phase 3 trial results suggest daratumumab, which is approved for multiple myeloma, may also be effective at reducing relapse risk in neuromyelitis optica spectrum disorder.

News All Time

FDA Accepts, Grants Priority Review to Veligrotug BLA for Thyroid Eye Disease

FDA Accepts, Grants Priority Review to Veligrotug BLA for Thyroid Eye Disease

FDA Extends PDUFA Date for Reproxalap in Dry Eye Disease to March 2026

FDA Extends PDUFA Date for Reproxalap in Dry Eye Disease to March 2026

6 Ophthalmology Headlines You Missed in October 2025

6 Ophthalmology Headlines You Missed in October 2025

New Parameters for Faster Geographic Atrophy Progression Established, with Srinivas Sadda, MD Srinivas Sadda, MD

The pooled sham cohorts of the OAKS and DERBY trials have revealed a series of indicators for faster geographic atrophy lesion growth.

OCU-410 Gene Therapy Preserves Visual Acuity and Slows GA Lesion Progression, with Jay Chhablani, MD Jay Chhablani, MD

Recent phase 1/2 trial data indicate the safety and efficacy of the surgical, subretinal injection in monitoring cellular homeostasis.

Intravitreal UBX1325 Shows Efficacy in Diabetic Retinopathy, DME, with Dante Pieramici, MD Dante J. Pieramici, MD

Results from the BEHOLD and ASPIRE trials indicate the long lasting effects of UBX1325 in improving retinal function and structure.

Q3 2025 Recap: Ophthalmology News and Updates Ryan Livingston

The Q3 recap for ophthalmology spotlights major FDA decisions and major clinical trial updates in a variety of diseases.

Psoriasis Associated with Risk of Age-Related Macular Degeneration Ryan Livingston

Based on 3 propensity-matched control groups, patients with psoriasis can have anywhere from a 40% to 56% higher risk.

Correlation Between Diabetes and Risk of Uveitis Confirmed in Recent Study Ryan Livingston

In addition to type 1 and 2 diabetes, diabetic retinopathy substantially increases the risk of developing and worsening uveitis.

Dyslipidemia May Delay Macular Hole Closure After Surgery Ryan Livingston

A recent study highlights correlations between later healing, triglyceride levels, and total cholesterol in patients receiving MH.

FDA Approves Incision-Free Topical Therapy Epioxa for Keratoconus Ryan Livingston

This approval represents an alternative method for approaching this undertreated disease, shortening recovery while minimizing invasiveness.

FDA Approves Adalimumab-aaty (Yuflyma) Pediatric Indications in Hidradenitis Suppurativa, Uveitis Abigail Brooks, MA

The FDA approved expanded indications for adalimumab-aaty (Yuflyma) and its unbranded version to include the treatment of adolescent HS and pediatric UV.

Brolucizumab Outperforms Aflibercept in DME Regardless of Prior Treatment

Brolucizumab Outperforms Aflibercept in DME Regardless of Prior Treatment

GLP-1 RAs May Influence Development of Nonexudative AMD in Patients With Obesity Ryan Livingston

Although no direct correlation can be drawn, these findings suggest a possible ocular benefit from GLP-1 RAs compared to other weight loss drugs.

Outlook Therapeutics Resubmits Biologics License Application for ONS-5010 for Wet AMD

Outlook Therapeutics Resubmits Biologics License Application for ONS-5010 for Wet AMD

Temporal artery ultrasound in the real-time diagnosis of stroke of the eye

For most of us, the phrase "stroke of the eye" sounds like a metaphor. But for UK HealthCare's Jagannadha "Jay" Avasarala, M.D., Ph.D., it's a literal and urgent diagnosis—one that could mean the difference between sight ...

Recommended News For You

Dementia-like protein buildup found in pancreas cells before cancer develops

To automate the biopharmaceutical facilities of Reliance Life Sciences, ABB India has won the contract.

Breast cancer screening in women's 40s can save lives, study says

Cancer detection recovered following pandemic disruptions

Study reveals crucial gaps in oral cancer awareness in Middle East and North Africa

Is Laughter Good for Blood Glucose Control?

Charles III, King of Kings, is Cancerous.

Recommended Articles For You

The Dark Side of Melanoma: Uncovering the Risk Factors and Prevention Strategies 

IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System 

The Power of Romiplostim in Treating Low Platelet Counts  

The Science Behind Thrombolytic Drugs and Their Benefits  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

BMTs that are "half-matched" are effective in treating severe sickle cell disease.

2.

Active Surveillance Lawsuits; More Eligibility for Studies; Biosimilars Make News.

3.

Aspirin for CRC Risk Reduction May Benefit Unhealthy People Most

4.

Waiting for a Sharp Increase in Prostate Cancer Cases.

5.

Prostate cancer Q&A: Improving detection and reducing overtreatment

1.

Mechanistic Depth and Clinical Impact of Rusfertide, Onyvide, IV Avastin, and Pemfexy

2.

Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources

3.

Hepatocellular Carcinoma: Emerging Trends and Innovations in Diagnosis and Management

4.

How to Manage Dic with the Right Treatment Approach

5.

Machine Learning in Genomic Analysis for Early Lung Cancer Detection: Key Advances and Insights

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

2.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

3.

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

4.

Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot